Category: Business

As per Fact.MR, a market research and competitive intelligence provider, the hyperbaric oxygen therapy (HBOT) devices market was valued at US$ 4.02 Bn in 2021.

At 1.5 to 3 times the average atmospheric pressure, hyperbaric oxygen therapy devices supply 100% pure oxygen to the bodily tissues. Excess oxygen in the circulation encourages the production of white blood cells and leucocytes, which fight bacteria, as well as the secretion of stem cells, which aids in speedier healing and the restoration of normal body function.

Hyperbaric oxygen therapy devices are used to treat chronic problem wounds by delivering oxygen to all body tissues through monoplace HBOT chambers, multiplace HBOT chambers or topical HBOT chambers.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7258

Key Segments Covered in Hyperbaric Oxygen Therapy Devices Industry Research

• Hyperbaric Oxygen Therapy Devices Market by Product:

  • Monoplace HBOT Devices
  • Multiplace HBOT Devices

• Hyperbaric Oxygen Therapy Devices Market by Application:

  • Wound Healing
  • Decompression Sickness
  • Infection Treatment
  • Gas Embolism

• Hyperbaric Oxygen Therapy Devices Market by Region:

  • North America Hyperbaric Oxygen Therapy Devices Market
  • Europe Hyperbaric Oxygen Therapy Devices Market
  • Asia Pacific Hyperbaric Oxygen Therapy Devices Market
  • Latin America Hyperbaric Oxygen Therapy Devices Market
  • Middle East & Africa Hyperbaric Oxygen Therapy Devices Market

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7258

Competitive Landscape

Rising investments by key players in R&D and the development of hyperbaric oxygen therapy products will be vital to preserving a competitive edge, with regular alliances being formed in an attempt to diversify product portfolios and increase market share.

For instance,

• In November 2019, AHA Hyperbarics introduced the AHA Flex V2, a new model of innovative high-pressure medical hyperbaric chambers that are specifically built to meet the growing need for HBOT safety and efficacy.

COVID-19 Impact on Sales of Hyperbaric Oxygen Therapy Products

The COVID-19 pandemic significantly impacted the healthcare industry. The use of hyperbaric oxygen therapy devices as an alternate treatment for COVID-19-related hypoxia has grown in favor. Rising acceptance as an emergency investigative device supported the industry growth during the pandemic.

Increasing government and private studies demonstrating hyperbaric oxygen therapy’s high effectiveness in improving survival rates will boost market demand over the coming years.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7258

Hyperbaric oxygen therapy devices are becoming more common in the healthcare system as the prevalence of wound site infection rises. Rapid healing necessitates an abundance of oxygen. Hyperbaric oxygen therapy involves exposing the body to 100% oxygen in the injured area in order to speed up the healing process.

Because of the rising occurrences of obesity and diabetes around the world, demand for hyperbaric oxygen therapy systems in wound healing applications will rise. Segment growth will be fueled by factors such as rising healthcare expenses and an ageing population. One of the few aspects that can be attributed to the greatest market share is the availability of improved solutions for the treatment of chronic wounds.

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The global medical device market is undergoing significant changes owing to technological advancements to aid human health. The market is expected to expand at a CAGR of more than 5% with significant contribution from the isolation market over 2022-2032. Rapid increase in biologically-contaminated patients with COVID -19 has propelled the isolation market.

The portable isolation room market increased in valuation from US$ 31.4 Mn in 2017 to US$ 43.5 Mn in 2021, reflecting a CAGR of 8.5%. The sudden outburst caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) saw a quick increase in infected patients globally.

Rapid surge in novel coronavirus infectious patients with various strains resulted in increased demand for hospitals, hospital beds, and ICUs. However, limited expansion of hospitals against the upsurge in the requirement for patient isolation stimulated the increase in demand for portable patient isolation rooms.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7253

Key Segments of Portable Isolation Room Industry Survey

• Global Portable Isolation Room Market by Product:

  • Portable Isolation Rooms
  • Portable Isolation Pods

• Global Portable Isolation Room Market by Occupancy:

  • Single Occupancy Portable Isolation Rooms
  • Multiple Occupancy Portable Isolation Rooms

• Global Portable Isolation Room Market by Sales Channel:

  • Direct Sales of Portable Isolation Rooms
  • Indirect Sales of Portable Isolation Rooms

• Global Portable Isolation Room Market by Region:

  • North America Portable Isolation Rooms Market
  • Latin America Portable Isolation Rooms Market
  • Europe Portable Isolation Rooms Market
  • East Asia Portable Isolation Rooms Market
  • South Asia & ASEAN Portable Isolation Rooms Market
  • Oceania Portable Isolation Rooms Market
  • MEA Portable Isolation Rooms Market

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7253

Competition Landscape

Key manufacturers of portable isolation rooms are Gama Healthcare, Adart Publicity, Blumed Response System, Biobase, ICARELIFE, MRC, Nippon Medical & Chemical Instruments Co., Ltd, Escoaster, Portafab, Mecart, ATA Medical, and ISOVAC.

The main principle of an isolation room is to prevent the communication of microorganisms from colonized or infected patient to other patients, hospital staff, etc. Hence, the quality of a patient isolation room is very essential.

• Presenting an example of ICARELIFE – it ensures that each product goes through testing at the factory before shipping. All components can be installed on-site by a technician and the product has a unique serial number allowing traceability during its lifecycle.

Moreover, collaboration and partnerships for the development of positive and negative pressure isolation rooms and the supply products on time is a key trend among tier-1 manufacturers of portable isolation rooms.

Fact.MR has provided detailed information about the price points of top portable isolation room manufacturers positioned across regions, in addition to providing sales growth information, production capacity, and speculative production expansion, in the recently published report.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7253

Which Occupancy is High in Portable Isolation Rooms?

Under the occupancy segment, the portable isolation room market is segmented into single and multiple occupancy portable isolation rooms.

The single occupancy portable isolation rooms segment is forecast to dominate the market with a market share of 64.6% in 2022, and is projected to witness growth at 4.5%.

Prior to COVID-19, one of the key uses of portable isolation rooms was in war zones to provide a safe environment to the defense forces to recover. In such a scenario, multiple occupancy isolation rooms were of preference; however, the sudden hit of the dangerous virus gave rise to demand for single patient isolation rooms among the civil population.

Some single patient isolation rooms are built with personal en suite bathrooms and anterooms, which is creating a new trend. The multiple occupancy segment holds 34.8% of the overall market share, and is projected to expand at a CAGR of 4.3% over the forecast years of 2022-2032.

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

 

The consumption of reprocessed medical devices to rise at an impressive CAGR of 14.9% from 2021 to 2028. In 2020, the global reprocessed medical devices market was worth US$ 2.05 Bn, and the market is anticipated to surge to a valuation of US$ 5.9 Bn by the end of 2028.

Reusable medical devices have seen a rise in demand and preference from several healthcare institutions as they struggle to manage high costs and increasing healthcare expenditure.

To remain ‘ahead’ of your competitors, request a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=7251

Prominent Key players of the Reprocessed Medical Devices market survey report:

• Stryker
• Medline Industries Inc.
• ReNu Medical
• LUMITOS AG
• Vanguard AG
• Johnson & Johnson
• Sterilmed Inc.
• Hygia Health Services Inc.
• Centurion Medical Products Corporation
• Siemens Healthcare
• Philips Healthcare
• GE Healthcare
• Suretech Medical Inc.

Key Segments Covered in Reprocessed Medical Devices Industry Research

• Reprocessed Medical Devices Market by Device Type:

  • Cardiovascular Devices
    • Blood Pressure Cuffs/Tourniquet Cuffs
    • Cardiac Stabilization and Positioning Devices
    • Compression Sleeves (DVT)
    • Diagnostic Electrophysiology Catheters
    • Electrophysiology Cables
  • General Surgery Devices
    • Balloon Inflation Devices
    • Infusion Pressure Bags
  • Laparoscopic Devices
    • Endoscopic Trocars & Components
    • Harmonic Scalpel
  • Orthopedic External Fixation Devices
  • Gastroenterology Biopsy Forceps

• Reprocessed Medical Devices Market by Region:

  • North America Reprocessed Medical Devices Market
  • Latin America Reprocessed Medical Devices Market
  • Europe Reprocessed Medical Devices Market
  • East Asia Reprocessed Medical Devices Market
  • South Asia & Oceania Reprocessed Medical Devices Market
  • MEA Reprocessed Medical Devices Market

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=7251

The insights for each vendor consists of:

• Company profile
• SWOT analysis
• Main market information
• Market share
• Revenue, pricing and gross margin

What insights does the Reprocessed Medical Devices Market report provide to the readers?

• Reprocessed Medical Devices fragmentation on the basis of product type, end use, and region.
• Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
• Collaborations, R&D projects, acquisitions, and product launches of each Reprocessed Medical Devices player.
• Various regulations imposed by the governments on the consumption of Reprocessed Medical Devices in detail.
• Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global Reprocessed Medical Devices.

Full Access of this Report Is Available at: https://www.factmr.com/checkout/7251

The report covers following Reprocessed Medical Devices Market insights and assessment that are helpful for all participants involved in the Reprocessed Medical Devices market:

• Data on recently introduced regulations and their impact on key industries and on demand in Reprocessed Medical Devices
• Latest industry Analysis on Reprocessed Medical Devices Market, with key analysis of market drivers, trends, and influencing factors
• Key trends Analysis of Reprocessed Medical Devices Market and changing consumer preferences in major industries.
• Changing Reprocessed Medical Devices demand and consumption of diverse products
• Major trends underlining funding by key investors in numerous countries
• New investment opportunities in diverse technology and product or service types
• Comprehensive data and Competitive analysis of Reprocessed Medical Devices major players
• Reprocessed Medical Devices Market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
• Reprocessed Medical Devices demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth

Questionnaire answered in the Reprocessed Medical Devices Market report include:

• How the market for Reprocessed Medical Devices has grown?
• What is the present and future outlook of the global Reprocessed Medical Devices on the basis of region?
• What are the challenges and opportunities for the Reprocessed Medical Devices?
• Why the consumption of Reprocessed Medical Devices highest in region?
• In which year segment is expected to overtake segment?

Read Our Latest Article on Healthcare Domain  https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The that global sales of Ophthalmic Ultrasound Devices Market in 2021 was held at US$ 432.2 Mn. With 9.0%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth. A-Scan is expected to be the highest revenue generating segment, accounting for an expected CAGR rate of 9.1% during 2022 – 2032.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7247

Key Points Covered in Ophthalmic Ultrasound Devices Market Survey:

• Market Estimates and Forecasts (2017-2032)
• Key Drivers and Restraints Shaping Market Growth
• Segment-wise, Country-wise, and Region-wise Analysis
• Competition Mapping and Benchmarking
• Market Share Analysis
• COVID-19 Impact on Ophthalmic Ultrasound Devices Market and How to Navigate
• Recommendation on Key Winning Strategies

Market Segments Covered in Ophthalmic Ultrasound Devices Market Analysis

• By Product Type

  • B-Scan
  • A-Scan
  • Combined
  • Pachymeter
  • Ultrasound Bio Microscope

• By Mobility

  • Portable
  • Standalone

• By End Use

  • Hospitals
  • Ambulatory Surgery Centers
  • Ophthalmology Clinics
  • Others

• By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7247

Competitive Analysis

The leading players are focusing on growth strategies, such as innovations in the existing product, frequent product launches, and mergers& acquisitions. Some of the recent developments of key Ophthalmic Ultrasound Devices providers are as follows:

• In March 2019, Quantal medical received U.S. FDA approval for the launch of its product called ABSolu.
• In April 2019, Lantheus announced in April that it would combine its microbubble technology with Cerevast’s ocular ultrasound device for the treatment of retinal vascular occlusion. This could be an entryway for newer RVO technologies in the years ahead, which may increase the effective use of recently developed ophthalmic ultrasound systems. Cerevast’s investigational ocular ultrasound program is undergoing a Phase 2b clinical trial in the second quarter of 2019.

Similarly, recent developments related to companies offering Ophthalmic Ultrasound Devices have been tracked by the team at Fact.MR, which are available in the full report.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7247

What are the insights about segment A-Scan?

The A-Scan segment is expected to register highest CAGR of 9.1%. One of the primary elements which is expected to encourage sector growth is the high use of A-scan equipment for pre-operative viewing of a detached retina in circumstances such as vitreous haemorrhage, peri-orbital trauma, or lens opacification. A-scan offers significant advantages in cataract procedures, resulting in considerable demand. Furthermore, A-scan employs the most up-to-date transducer and electronic technology in ophthalmic practises, ensuring high reliability and accuracy. As a result, the segment is likely to increase at a considerable rate in the coming years.

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The global sales of Lateral Flow Assay in 2021 was held at US$ 7.2 Bn. With 4.7%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth. Benchtop Readers is expected to be the highest revenue generating product, while Clinical Testing is considered to be the highest revenue generating application with a CAGR of 4.6% and 5% respectively during 2022 – 2032.

Given the multiple advantages that lateral flow technology provides, it is becoming the approach of choice for infectious disease diagnostics. The market’s growth can be due to the rising prevalence of infectious diseases, growing elderly population and the growing popularity of point-of-care testing.

The market is also expected to gain from the growing popularity of self-diagnosis, which is driving demand for home-based lateral flow assay devices. Continuing technological breakthroughs in the field of lateral flow tests are also boosting market expansion. These efforts are aimed at improving the selectivity, sensitivity, and quantitation of these tests. In addition, growth is boosted by the integration of enhanced quantification systems, novel labels, and simultaneous detection approaches.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7246

Market Segments Covered in Lateral Flow Assay Industry Analysis

• By Product Type

  • Lateral Flow Readers
  • Digital/Mobile Readers
  • Benchtop Readers
  • Kits & Reagents

• By Application

  • Drug Development & Quality Testing
  • Clinical Testing
  • Veterinary Diagnostics
  • Food safety & Environment Testing

• By Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

• By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7246

Competitive Analysis

Product approvals, new product releases, acquisitions, collaborations, and innovations are all important methods used by leading market players to maintain their market position.

According to the market research analysis, partnerships and expansion have been the prominent development in Lateral Flow Assay market in recent year. Abbott Laboratories; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Bio-rad Laboratories, Inc.; Biomérieux SA; Quidel Corporation; Hologic, Inc.; Perkinelmer, Inc.; Merck KGAA; Becton, Dickinson and Company; Siemens Healthineers; Danaher Corporation; Qiagen N.V. are the prominent providers of Lateral Flow Assay services.

The leading players in the Lateral Flow Assay market have been implementing various tactics to increase growth potential over the next years. Furthermore, the presence of many rising and well-established firms has defined the market for Lateral Flow Assay. Well-known market players are pursuing a variety of tactics, including acquisitions, mergers, and new product releases. Some of the recent developments of key Lateral Flow Assay providers are as follows:

• In October 2021, Bio-Plex Pro human immunoglobulin A (IgA) and immunoglobulin M (IgM) SARS-CoV-2 antigen panels were launched by Bio-Rad Laboratories, a life science research and clinical diagnostic products firm, to detect IgA and IgM antibodies against four SARS-CoV-2 antigens.
• In September 2021, The FDA granted ANP Technologies Inc. authorization to use its NIDS COVID-19 Antigen Rapid Test Kit as a treatment for the act of NANs in children as well as adults with suspected COVID-19. Following analyses in the United States, this test utilizes a technology by ANP.
• In October 2020, Siemens Healthineers launched a rapid antigen test for the detection of SARS-CoV-2.
• In September 2020, Roche announced the launch of the SARS-CoV-2 fast antigen test for markets that accept the CE Mark. Roche also plans to apply to the US Food and Drug Administration for an Emergency Use Authorization (EUA) (FDA).

Similarly, recent developments related to companies offering Lateral Flow Assay have been tracked by the team at Fact.MR, which are available in the full report.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7246

What Factors are driving the Lateral Flow Assay Revenue in the US?

The presence of the key market leaders in the United States has facilitated lateral flow assays market growth in the country. Furthermore, a favorable reimbursement scenario and advanced point-of-care testing facilities promote the lateral flow assays market in the United States.

Alongside, the region’s high rate of respiratory illnesses such COVID-19, influenza, and RSV is driving up demand for detection and treatment. The availability of government funding for research and the presence of well-established healthcare infrastructure are expected to boost the market for lateral flow assays in the country. The National Institute of Health (NIH) spent US$ 248.7 Mn for the development of new technologies to overcome issues related with COVID-19 testing in July 2020.

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The global drainage bottles market analysis report by Fact.MR shows that the market was worth US$ 473.3 million in 2021, and it is predicted to grow at a CAGR of 8.5% from 2022 to 2032. The market is expected to provide an absolute dollar opportunity of US$ 640 Mn. The projected market growth crossed the historical average which stands out to be 7.9%.

The Chest Drainage segment is expected to outpace all the other segment by growing at CAGR of 10.4% in the period from 2022-2032.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7245

Market Segments Covered in Drainage Bottles Market Analysis

• By Application

  • Chest Drainage
  • Accel Evacuated
  • Peritoneal Drainage
  • Urostomy/ Urinary
  • Wound Drainage
  • Other Applications

• By End-use

  • Hospitals & Clinics
  • Homecare
  • Nursing Facilities
  • Other End-uses

• By Region type

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Others
  • APAC
    • India
    • China
    • Japan
    • South Korea
    • Australia
    • Others
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7245

Competitive Analysis

The leading companies in the Global Drainage Bottles Market are focussing on bringing technological innovations to the industry through increased R&D activity. To strategically grow in the coming years, these businesses are employing a variety of techniques. Market participants frequently diversify their portfolio, expand their distribution network, develop new products and expand their business through strategic mergers and acquisitions.

The key competitors in the Drainage Bottles Market are PAHSCO, PFM Medical, Inc., Lily Medical Corporation, Hospitech, MEDINORM Medizintechnik GmbH, Jigsaw Medical, LLC, B. Braun Medical Inc., Sterimed Group, and Rocket Medical plc.

The recent developments in the Drainage bottles market which were being channelised by market players are as follows:

• In Dec 2021, PAHSCO received the 18th Golden Root Award held by Taiwan Industrial Technology Promotion Association. This award was given to an excellent corporate representatives with “localization and internationalization” to remark their excellent contributions to Taiwan’s economy.
• In June 2021, PAHSCO had donated 10,000 closed suction systems to frontline healthcare workers as a gesture to help the government fight the pandemic while also satisfying its CSR duty.
• In April 2021, PFM medical debuted its new subsidiary, PFM medical expert, which gives guidance and support on all aspects of quality management, MDR compliance and clinical project management.

Similarly, recent developments related to companies offering drainage bottles have been tracked by the team at Fact.MR, which are available in the full report.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7245

Among the application wise categorisation which segment is expected to show the best results and why?

On the basis of Application, the Chest drainage segment is expected to grow fastest with a CAGR of 10.4% during the forecasted period of 2022-2032. This has been attributed to the rising frequency of cardiovascular disorders and a sudden increase in the headcount of patients requiring thoracic surgeries. According to the World Health Organization, over 17.9 million people died in 2019 from cardiovascular illnesses. In addition, coronary artery disease has affected 18.2 million adults globally aged 20 and above.

What are the prospects of accel evacuated segment in coming years? How this segment is driven?

From 2022 to 2032, the accel evacuated category is predicted to grow at a CAGR of 8.7%. The Global Drainage bottle market is being driven by a number of factors, including the introduction of new products by major market participants and the rising occurrence of burn injuries.

Based on the American Burn Association, approximately 450,000 major burn injuries occur in the U.S every year. According to the World Health Organisation, burns are a worldwide chronic health issue, with more than 180,000 deaths each year. The majority of burns occur in low and middle-income countries, with many of them occurring in the African and Southeast Asian countries.

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The global sales of Cochlear Implant Market in 2021 was held at US$ 2.2Bn. With 14.1%, theprojectedmarketgrowthduring2022 – 2032 is expected to be significantly higher than the historical growth. Unilateral Implants are expected to be the highest revenue generating segment, projected to grow at a CAGR of over 14.3% during 2022 – 2032.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7244

Market Segments Covered in Cochlear Implant Market Analysis

• By Fitting Type

  • Unilateral Implants
  • Bilateral Implants

• By End-Use

  • Adult
  • Pediatric

• By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7244

Competitive Analysis

Players in the market are constantly developing innovative solutions as well as extending their product offerings. To help healthcare organisations combat the Covid-19 pandemic, and preserve competitive advantage in the market, the companies are focused on their alliances, technology collaborations, and product launch strategies.

Some of the recent developments of key Cochlear Implant providers are as follows:

• In April 2022, Cochlear Ltd.‘s Cochlear Nucleus Implants were approved by the FDA for the treatment of unilateral hearing loss (ULH) or single-sided deafness (SDD).
• In January 2022, TODOC, a South Korean company that specializes in neural prosthetic devices and neuromodulation systems, has announced that its artificial cochlear device ‘SULLIVAN’ will be unveiled at the “CES 2022” in Las Vegas.
• In June 2021, Oticon Medical received premarket approval (PMA) from the United States Food and Drug Administration (U.S. FDA) for its Neuro System (cochlear implant system) to treat patients aged 18 years or more with bilateral severe-to-profound sensorineural hearing loss who receive limited benefit from appropriately fitted hearing aids.
• In December 2020, after receiving FDA approval to expand its product offerings, Sonova launched two new sound processors, Sky CI Marvel and Nada CI Marvel.

Similarly, recent developments related to companies Cochlear Implant services have been tracked by the team at Fact.MR, which are available in the full report.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7244

What is the impact of Covid-19 on Cochlear Implant Market?

COVID-19 established limitations on audiology surgery and therapy services when it first appeared. The possibility of aerosolizing the virus while drilling in the mastoid cavity increased the danger of infection during neurotological (a subset of ENT) procedures. As a result, individuals were screened for COVID-19 prior to surgery, which caused procedures to be postponed. In addition, appointments for the rehabilitation phase following a cochlear implant operation were cancelled or postponed.

Surgical procedures are fewer today than in the early months of the conflict as a result of eased restrictions against coronaviruses in several countries. Although this contributed to the emergent risk of cochlear implant surgery and other procedures, it also led to thrive in brand-new study. At Nottingham University Hospitals in July 2020, ENT doctors and researchers created a new personal protective equipment solution for cochlear implantation surgeries, which enabled the procedure to be completed more quickly.

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The study on the Global Antibody Drug Conjugates Contract Market Insights published by Fact.MR is a comprehensive analysis of the key factors that are likely to determine the growth of Antibody Drug Conjugates Contract Market Insights in the upcoming years. Further, the study dives deep to investigate the micro and macro-economic parameters that are expected to influence the global scenario of the Antibody Drug Conjugates Contract Market Insights during the forecast period.

The report examines the current trends, growth opportunities, restraints, and market drivers that are projected to influence the overall dynamics of the Antibody Drug Conjugates Contract Market Insights in the assessment period.

For critical insights on this market, request for More Info –  https://www.factmr.com/connectus/sample?flag=S&rep_id=7243      

Antibody Drug Conjugates Contract Market Insights Segmentation

• By Condition Type
  • Myeloma
  • Lymphoma
  • Breast Cancer
  • Other Condition Types
• By Application
  • Cleavable Linker
  • Non-cleavable Linker
• By Region
  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=7243      

Essential Takeaways from the Antibody Drug Conjugates Contract Market Insights Report

• Comparison of prominent players operating in the Antibody Drug Conjugates Contract Market Insights.
• Recent developments and key strategies adopted by Antibody Drug Conjugates Contract Market players.
• Study of the micro and macro-economic growth indicators.
• Impact of the various factors on the value chain of the Antibody Drug Conjugates Contract Market Insights.
• Growth opportunities for emerging market players in various regional markets.
• Current trends influencing the scenario of the Antibody Drug Conjugates Contract Market Insights.

Important queries related to the Antibody Drug Conjugates Contract Market Insights addressed in the report:

1. Who are the most prominent players in the Antibody Drug Conjugates Contract Market Insights?
2. What are the factors that are likely to hinder the growth of the Antibody Drug Conjugates Contract Market Insights during the forecast period?
3. Why is the concentration of tier-1 companies high in specific region?
4. How are the soaring prices of raw materials impacting the demand for Antibody Drug Conjugates Contract Market?
5. Why are Antibody Drug Conjugates Contract Market players eyeing opportunities in particular region?

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7243      

Why Choose Fact.MR

• One of the most established market research companies in India
• Round the clock customer support for clients across the globe
• Tailor-made reports available without additional costs
• Analysis of markets in over 150 countries
• Data collected from credible primary and secondary sources

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The pulmonary arterial hypertension (PAH) market was valued at US$ 5.2 Bn in 2020 and is projected to accelerate at a CAGR of 5.4% to reach US$ 13.5 Bn by 2028.

Click here to get a sample report (with full table of contents, tables and figures):-

https://www.factmr.com/connectus/sample?flag=S&rep_id=7234

Prominent Key players of the Pulmonary Arterial Hypertension (PAH) market survey report:

• Gilead Sciences Inc.
• Pfizer, Inc.
• GlaxoSmithKline plc
• Novartis International AG
• Bayer HealthCare
• United Therapeutics Corp

Need more information on our reporting methodology? Click here:-

https://www.factmr.com/connectus/sample?flag=RM&rep_id=7234

Key Segments Covered in Pulmonary Arterial Hypertension Industry Research

• Pulmonary Arterial Hypertension Market by Drug Class:

  • Prostacyclin & Prostacyclin Analogs
  • Endothelin Receptor Antagonists (ERAs)
  • Phosphodiesterase-5 (PDE-5) Inhibitors
  • Soluble Guanylate Cyclase (sGC) Stimulators

• Pulmonary Arterial Hypertension Market by Pipeline Analysis:

  • Early-stage Drug Candidates (Phase I & Phase II)
  • Late-stage Drug Candidates (Phase III & Registration Phase)

• Pulmonary Arterial Hypertension Market by Region:

  • North America Pulmonary Arterial Hypertension Market
  • Europe Pulmonary Arterial Hypertension Market
  • Asia Pacific Pulmonary Arterial Hypertension Market
  • Latin America Pulmonary Arterial Hypertension Market
  • Middle East & Africa Pulmonary Arterial Hypertension Market

The insights for each vendor consists of:

• Company profile
• SWOT analysis
• Main market information
• Market share
• Revenue, pricing and gross margin

What insights does the Pulmonary Arterial Hypertension (PAH) Market report provide to the readers?

• Pulmonary Arterial Hypertension (PAH) fragmentation on the basis of product type, end use, and region.
• Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
• Collaborations, R&D projects, acquisitions, and product launches of each Pulmonary Arterial Hypertension (PAH) player.
• Various regulations imposed by the governments on the consumption of Pulmonary Arterial Hypertension (PAH) in detail.
• Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global Pulmonary Arterial Hypertension (PAH).

Full Access of this Report Is Available at

https://www.factmr.com/checkout/7234

The report covers following Pulmonary Arterial Hypertension (PAH) Market insights and assessment that are helpful for all participants involved in the Pulmonary Arterial Hypertension (PAH) market:

• Data on recently introduced regulations and their impact on key industries and on demand in Pulmonary Arterial Hypertension (PAH)
• Latest industry Analysis on Pulmonary Arterial Hypertension (PAH) Market, with key analysis of market drivers, trends, and influencing factors
• Key trends Analysis of Pulmonary Arterial Hypertension (PAH) Market and changing consumer preferences in major industries.
• Changing Pulmonary Arterial Hypertension (PAH) demand and consumption of diverse products
• Major trends underlining funding by key investors in numerous countries
• New investment opportunities in diverse technology and product or service types
• Comprehensive data and Competitive analysis of Pulmonary Arterial Hypertension (PAH) major players
• Pulmonary Arterial Hypertension (PAH) Market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
• Pulmonary Arterial Hypertension (PAH) demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth

Questionnaire answered in the Pulmonary Arterial Hypertension (PAH) Market report include:

• How the market for Pulmonary Arterial Hypertension (PAH) has grown?
• What is the present and future outlook of the global Pulmonary Arterial Hypertension (PAH) on the basis of region?
• What are the challenges and opportunities for the Pulmonary Arterial Hypertension (PAH)?
• Why the consumption of Pulmonary Arterial Hypertension (PAH) highest in region?
• In which year segment is expected to overtake segment?

For More Insights of Fact.MR Trending Report:

https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The preventive healthcare technologies and services market is projected to surge ahead at an astronomical CAGR of 13% from 2021 to 2028. In 2020, revenue from preventive healthcare technologies and services was US$ 217.1 Mn, which is anticipated to reach US$ 557.5 Mn by the end of 2028.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7233

Key Segments Covered in Preventive Healthcare Technologies and Services Industry Research

• Preventive Healthcare Technologies and Services Market by Early Detection & Screening Technologies:

  • Personalized Medicines
  • Automated Screening
  • Other Advanced Screening Tests

• Preventive Healthcare Technologies and Services Market by Prophylaxis Technologies:

  • Flu Vaccines
  • Meningococcal Vaccines
  • Combined Tetanus-Diphtheria-Pertussis Vaccines
  • Human Papillomavirus Vaccines
  • Other New Vaccines

• Preventive Healthcare Technologies and Services Market by Advanced Technologies to Reduce Errors:

  • Electronic Prescribing
  • Computerized Provider Order Entry Systems
  • Clinical Decision Support Systems
  • Automated Prescription, Formulation, and Dispensing
  • Smart Infusion Pumps
  • Smart Packaging

• Preventive Healthcare Technologies and Services Market by Chronic Disease Management Technologies:

  • Blood Pressure Monitors
  • Glucose Monitors
  • Cardiac Monitors
  • Asthma Monitors

• Preventive Healthcare Technologies and Services Market by Region:

  • North America Preventive Healthcare Technologies and Services Market
  • Latin America Preventive Healthcare Technologies and Services Market
  • Europe Preventive Healthcare Technologies and Services Market
  • East Asia Preventive Healthcare Technologies and Services Market
  • South Asia & Oceania Preventive Healthcare Technologies and Services Market
  • MEA Preventive Healthcare Technologies and Services Market

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7233

Competitive Landscape

Key preventive healthcare technology and service providers are focusing on increasing awareness regarding preventive medicine and are launching new initiatives to boost the same.

• In April 2022, the AIG Hospital based in Hyderabad, India, announced the launch of new wellness centers that are solely aimed at revolutionizing preventive healthcare in India by increasing awareness about personalized and preventive medicines.
  

  Market Performance During COVID-19

  In 2020, the world was plagued with coronavirus infections which led to a global pandemic. The COVID-19 pandemic resulted in lockdowns across multiple nations that were put in place to curb the spread of coronavirus infections along with social distancing norms. Healthcare institutions across the world adopted digital healthcare technologies to improve functionality and lessen the increasing burden of coronavirus patients in these facilities.

  The pandemic boosted demand for preventive healthcare technologies and services and the market is expected to see a bright growth outlook in the post-pandemic era. Increasing awareness of preventive healthcare and its importance will be major factors driving growth in the post-pandemic era through 2028.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7233

“Rising Use of Vaccines Driving Demand for Prophylaxis Technologies”

Prophylactic measures have gained massive popularity in recent years and this trend is expected to be prominent over the forecast period as well. These measures enable the formulation of vaccines that facilitate the development of antibodies that help combat diseases.

Increased use of vaccines for diseases such as Ebola, Hepatitis C, COVID, and AIDS is also expected to bolster the growth of the prophylaxis technologies segment over the forecast period.

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com